Fierce Biotech | Glympse Bio clears first-in-human safety study of its injectable biosensors
/in In the News /by raincastleFirst-In-Human Data Supporting the Safety of Glympse Bio’s Biosensors are Presented at the AASLD 2020 Annual Meeting
/in Press Releases /by raincastleConversations in Healthcare | How Glympse Bio oversubscribed their Series B funding amidst the pandemic
/in In the News /by raincastleGlympse Bio to Present Clinical Data at the AASLD 2020 Annual Meeting
/in Press Releases /by raincastle35 Cambridgepark Drive
Suite 100
Cambridge, MA 02140
© 2022 Glympse Bio. All rights reserved.
Terms of Use | Privacy Policy | Other Policies
Design and development by RainCastle Communications.
Images by Liz Linder Photography.